HomeProductsBioactive CompoundsGPCR & G Protein TargetsGPCRSetipiprant
Chemical structure of CAS 866460-33-5

Setipiprant

CAS No.866460-33-5
MDL No.N/A
MFC24H19FN2O3
MW402.40
InChI KeyIHAXLPDVOWLUOS-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Setipiprant is a naphthalenecarboxamide.

CAS No.866460-33-5
Product NameSetipiprant
Heavy Atom Count30Rotatable Bond Count3
Atom Stereo Count0Bond Stereo Count0
HBA3HBD1
TPSA62.540 ŲCharge0
Exact Mass402.13797Complexity1319.78
pKa2.768XLogP4.217

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology • Vol. 13 • 2017
PMID: 28392807PMC: PMC5379543DOI: 10.1186/s13223-017-0183-z

Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonist.

Journal of medicinal chemistry • Vol. 56, Issue 12 • 2013
PMID: 23721423DOI: 10.1021/jm400122f

Documentation

Similar Products